Skip to main navigation Skip to search Skip to main content

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parellel-group Trial to Investigate the Efficacy & Safety of SPM 927 (400 mg & 600 mg/day) as Adjunctive Therapy in Subjects w/Partial Seizures w/or w/out Secondary Generalization

  • Beach, Robert (PI)

Project: Research

Project Details

StatusFinished
Effective start/end date06/2/04 → 06/1/06

Funding

  • Scirex Corporation: $33,265.44